Trice Brown, The Auburn Plainsman; Nobel laureate takes stance against allowing research to be intellectual property
"George Smith, recipient of a 2018 Nobel Prize for Chemistry, spoke to
a crowd of students and faculty about the problems that arise from
making publicly funded research intellectual property.
Smith said one of the greatest problems facing the scientific
research community is the ability of universities to claim intellectual
property rights on publicly funded research.
“I think that all research ought not to have intellectual — not to be
intellectual property,” Smith said. “It’s the property of everyone.”"
Issues and developments related to IP, AI, and OM, examined in the IP and tech ethics graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology", coming in Summer 2025, includes major chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Kip Currier, PhD, JD
Showing posts with label drug prices. Show all posts
Showing posts with label drug prices. Show all posts
Thursday, April 11, 2019
Sunday, March 19, 2017
One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights; NPR, March 16, 2017
Alison Kodjak, NPR;
One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights
"...Trump already has a weapon he could deploy to cut the prices of at least some expensive medications.
That weapon is called "march-in rights."...
...[L]ower prices could also make drug companies less eager to invest lots of money in new medications.
That's the trade-off the government has always had to wrestle with. But it's one Trump could very well decide is worthwhile.
"Perhaps we as a country would rather have lower drug prices and a little less innovation," [Sara Fisher] Ellison [an economist at MIT] said."
Subscribe to:
Posts (Atom)